Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Y. Kim
Total Records ( 4 ) for Y. Kim
  H. S Eom , C. K Min , B. S Cho , S Lee , J. W Lee , W. S Min , C. C Kim , M Kim and Y. Kim

Patients with multiple myeloma (MM) achieving high-quality responses, defined as a complete response (CR) and a very good partial response (VGPR) after transplant, benefit from high-dose therapy followed by autologous stem cell transplantation (ASCT). Induction pre-transplantation treatment with vincristine, doxorubicin and dexamethasone (VAD) is currently being replaced by new targeted agents with high anti-myeloma activity. The use of these novel agents may increase the CR + VGPR rate before ASCT, which may improve post-transplantation responses and survival.


We performed a retrospective analysis of 69 patients with MM who received bortezomib-containing regimens (n = 30) or VAD (n = 39) before collection of peripheral blood stem cells and ASCT.


Objective response rate (at least a partial response) prior to ASCT was documented in 27 (90%) of 30 and 31 (81.6%) of evaluable 38 patients with bortezomib-containing regimens and VAD, respectively. The difference between the two groups was not significant (P = 0.494). However, the high-quality response rate with VGPR or more in the bortezomib group was significantly higher compared with the VAD group (66.7% vs. 34.2%, respectively, P = 0.006). The superiority of bortezomib-containing regimens in the high-quality response rate remained significant for only the newly diagnosed patients (n = 16, P = 0.008). The engraftment data as well as stem cell harvesting were comparable between the two groups. The major bortezomib-related toxicities were thrombocytopenias and peripheral neuropathies; toxicities of VAD were hematologic and infectious. After ASCT, the difference between the two groups did not reach the level of statistical significance with respect to progression-free survival and overall survival (P = 0.498 and 0.835, respectively).


The results of this retrospective comparison of bortezomib-containing regimens with the VAD as induction treatment prior to ASCT for MM provided a demonstration of the superiority of bortezomib therapy in terms of achieving a high-quality response. However, survivals following ASCT did not differ according to the induction regimens.

  Y. Kim and T. Chae
  In a Very High Temperature Reactor (VHTR), the components of the next generational hydrogen production reactor, core and reflector are surrounded by graphite supports. Graphite materials, despite their excellent physical properties, oxidize easily above 500°C. For this reason, to prevent oxidation, a silicon carbide coating is often used. Among the physical vapor deposition methods, electron-beam coating easily develops cracks on the coating layer by thermal shock after application, forming a graphite oxidation path. In order to heal the cracks caused by thermal shock in the coating layer, this study adjusted the hydrogen ratio via. the Chemical Vapor Deposition (CVD) method and caused vapor distribution of SiC on specimens with cracks to heal. With a higher hydrogen ratio, the H2 dilution effect is intensified. This causes an enhancement in the crystallizability which changes the round-shaped microstructure into a faceted microstructure. Further, the higher the hydrogen ratio, the denser the microstructure becomes which causes higher oxidation resistivity as well. Consequently, this study found that the anti-oxidation effect was sharply increased when the healing of coating layer cracks occurred at the hydrogen ratio of 200 via. the CVD method.
  K Kuriyama , T Soshi , T Fujii and Y. Kim

The interaction between amygdala-driven and hippocampus-driven activities is expected to explain why emotion enhances episodic memory recognition. However, overwhelming behavioral evidence regarding the emotion-induced enhancement of immediate and delayed episodic memory recognition has not been obtained in humans. We found that the recognition performance for event memory differs from that for emotional memory. Although event recognition deteriorated equally for episodes that were or were not emotionally salient, emotional recognition remained high for only stimuli related to emotional episodes. Recognition performance pertaining to delayed emotional memory is an accurate predictor of the context of past episodes.

  K. H Chang , W Lee , D. M Choo , C. S Lee and Y. Kim

In this research, using direct measurements and Monte Carlo calculations, the potential dose reduction achieved by bismuth shielding in computed tomography was evaluated. The patient dose was measured using an ionisation chamber in a polymethylmethacrylate (PMMA) phantom that had five measurement points at the centre and periphery. Simulations were performed using the MCNPX code. For both the bare and the bismuth-shielded phantom, the differences of dose values between experiment and simulation were within 9 %. The dose reductions due to the bismuth shielding were 1.2–55 % depending on the measurement points, X-ray tube voltage and the type of shielding. The amount of dose reduction was significant for the positions covered by the bismuth shielding (34 – 46 % for head and 41 – 55 % for body phantom on average) and negligible for other peripheral positions. The artefact on the reconstructed images were minimal when the distance between the shielding and the organs was >1 cm, and hence the shielding should be selectively located to protect critical organs such as the eye lens, thyroid and breast. The simulation results using the PMMA phantom was compared with those using a realistically voxelised phantom (KTMAN-2). For eye and breast, the simulation results using the PMMA and KTMAN-2 phantoms were similar with each other, while for thyroid the simulation results were different due to the discrepancy of locations and the sizes of the phantoms. The dose reductions achieved by bismuth and lead shielding were compared with each other and the results showed that the difference of the dose reductions achieved by the two materials was less than 2–3 %.

Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility